July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
The role of VEGF Expression in Superior Limbic Keratoconjunctivitis
Author Affiliations & Notes
  • sabrina bergeron
    The MUHC - McGill Ocular Pathology Laboratory, Montreal, Quebec, Canada
  • Pablo Zoroquiain
    The MUHC - McGill Ocular Pathology Laboratory, Montreal, Quebec, Canada
  • Jade Marie Lasiste
    The MUHC - McGill Ocular Pathology Laboratory, Montreal, Quebec, Canada
  • Jacqueline Coblentz
    The MUHC - McGill Ocular Pathology Laboratory, Montreal, Quebec, Canada
  • Debra-Meghan Sanft
    Ophthalmology, McGill University, Montreal, Quebec, Canada
  • Devinder Cheema
    Ophthalmology, McGill University, Montreal, Quebec, Canada
  • Miguel N Burnier
    The MUHC - McGill Ocular Pathology Laboratory, Montreal, Quebec, Canada
  • Footnotes
    Commercial Relationships   sabrina bergeron, None; Pablo Zoroquiain, None; Jade Lasiste, None; Jacqueline Coblentz, None; Debra-Meghan Sanft, None; Devinder Cheema, None; Miguel Burnier, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1167. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      sabrina bergeron, Pablo Zoroquiain, Jade Marie Lasiste, Jacqueline Coblentz, Debra-Meghan Sanft, Devinder Cheema, Miguel N Burnier; The role of VEGF Expression in Superior Limbic Keratoconjunctivitis. Invest. Ophthalmol. Vis. Sci. 2018;59(9):1167.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Superior limbic keratoconjunctivitis (SLK) is a chronic and recurrent condition of unknown etiology. SLK is described as an inflammatory disease of the superior bulbar conjunctiva, limbus and cornea. Current medical and surgical treatments are aimed at reducing symptoms. However, relief is variable among patients and even after surgical removal, discomfort can recur. Previous studies suggest that SLK has a rich vascular density compared to normal conjunctiva. The purpose of this study is to determine if vascular endothelial growth factor (VEGF) expression is increased in SLK compared to patients without conjunctival disease.

Methods : In total, 12 surgically removed SLK samples from 9 patients were identified; 6 non SLK eyes were used as controls. FFPE specimens were stained using an anti-VEGF monoclonal antibody and automated immunohistochemistry was performed. The slides were digitalized and VEGF expression in the epithelium and conjunctival substantia propria was scored using a customized pixel count algorithm. Results were compared to VEGF expression in normal conjunctival samples. Vascular density for SLK was also scored (normal, high, clusters) by an experienced ocular pathologist.

Results : The histopathological findings observed in all cases (12/12) included acanthosis, hyperkeratosis and a decrease in the number of goblet cells, as classically described in SLK. Increased vascularization was observed in 75% (9/12) of SLK cases and three samples presented with vessel clusters. VEGF expression in epithelial cells was noted to be significantly elevated for all cases of SLK compared to controls (P=0.009). Similarly, VEGF expression in the substantia propria was higher in SLK samples compared to normal conjunctiva (P=0.027), regardless of vascular density.

Conclusions : VEGF levels are significantly elevated in the epithelium and substantia propria of the conjunctiva in SLK patients. The high expression of VEGF in both the substantia propria and epithelium indicates that this phenomenon may be independent of vascular density. Our data indicate that anti-angiogenic therapies may be beneficial for the treatment of SLK to improve patient symptoms and minimize recurrences due to the ubiquitous expression of VEGF.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×